Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Nuclear Medicine|November 19, 2020
Widespread Glial Activation in Primary Progressive Multiple Sclerosis Revealed by 18F-PBR06 PET: A Clinically Feasible, Individualized ApproachTarun Singhal, Eero Rissanen, John Ficke, et al.
Clinical Nuclear Medicine|March 28, 2023
Assessment of Microglial Activation in Alzheimer Disease Using 18 F-PBR06 PETKelsey Carter, Steven Cicero, Eero Rissanen, et al.
Clinical Nuclear Medicine|March 2, 2026
Sjögren Syndrome Associated Limbic Encephalitis and Its Longitudinal Brain FDG PET ManifestationsKriti Soni, Steven Cicero, Rizwana Syed, et al.
Clinical Nuclear Medicine|May 13, 2025
Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer's Disease DementiaTarun Singhal, Steven Cicero, Seth A Gale, et al.
American Journal of Alzheimer'S Disease and Other Dementias|March 9, 2023
Utility of Amyloid Positron Emission Tomography Imaging in Older Adults With Epilepsy and Cognitive DeclineRani A Sarkis, Seth A Gale, Hyun-Sik Yang, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 30, 2019
Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET studyTarun Singhal, Kelsey O'Connor, Shipra Dubey, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 10, 2020
Regional microglial activation in the substantia nigra is linked with fatigue in MSTarun Singhal, Steven Cicero, Hong Pan, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 29, 2022
Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 EncephalitisEero Rissanen, Kelsey Carter, Steven Cicero, et al.
Clinical Nuclear Medicine|April 17, 2024
Glial Activity Load on PET Reveals Persistent "Smoldering" Inflammation in MS Despite Disease-Modifying Treatment: 18 F-PBR06 StudyTarun Singhal, Steven Cicero, Eero Rissanen, et al.
Medrxiv : the Preprint Server for Health Sciences|July 14, 2025
Nasal foralumab treatment of PIRA induces regulatory immunity, dampens microglial activation and stabilizes clinical progression in non-active secondary progressive MSTanuja Chitnis, Tarun Singhal, Jonathan Zurawski, et al.
Pageof 2